Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
General Physiology and Biophysics|March 13, 2024
The role of endoplasmic reticulum stress-related genes in the diagnosis and subtyping of non-alcoholic fatty liver diseaseZihao Guo, Xiaoxiao Yu, Zhihao Fang, et al.
Biology|October 29, 2025
Transcriptomic Investigation of FoxM1-Mediated Neuroprotection by hAEC-Derived Exosomes in an In Vitro Ischemic Stroke ModelDong Wang, Jiaxin Liu, Liang Wu, et al.
ACS Omega|April 15, 2024
The Relationship between Droplet Density and the Defoliation Effect of Cotton Harvest AidsLi Duan, Zhihao Fang, Zechen Dou, et al.
Frontiers in Genetics|September 25, 2023
Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver diseaseXiaoxiao Yu, Zihao Guo, Zhihao Fang, et al.
Breast Cancer Research : BCR|January 6, 2025
Serum metabolomic profiling for predicting therapeutic response and toxicity in breast cancer neoadjuvant chemotherapy: a retrospective longitudinal studyZhihao Fang, Guohong Ren, Shouyu Ke, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 30, 2022
Determination of adenosine and its modifications in urine and plasma from breast cancer patients by hydrophilic interaction liquid chromatography-tandem mass spectrometryXiaoxiao Zhang, Yiqiu Hu, Xiujuan Hong, et al.
Metabolites|October 27, 2022
Simultaneous Determination of Methylated Nucleosides by HILIC-MS/MS Revealed Their Alterations in Urine from Breast Cancer PatientsZhihao Fang, Yiqiu Hu, Xiujuan Hong, et al.
General Physiology and Biophysics|August 14, 2024
Bioinformatics analysis of potential ferroptosis and non-alcoholic fatty liver disease biomarkersXiaoxiao Yu, Kai Yang, Zhihao Fang, et al.
BMC Pediatrics|July 10, 2026
Study on the construction and verification of intraoperative pressure injury risk prediction model for children undergoing cardiac surgeryZhihao Fang, Qiuyu Chen, Sini He, et al.
Journal of Inflammation Research|February 10, 2025
Identification of EGR1 as a Key Diagnostic Biomarker in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Through Machine Learning and Immune AnalysisXuanlin Wu, Tao Pan, Zhihao Fang, et al.
Pageof 6